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Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
Ubiquinone and menaquinone are membrane lipid-soluble carriers of electrons that
are essential for cellular respiration. Eukaryotic cells can synthesize ubiquinone but
not menaquinone, whereas prokaryotes can synthesize both quinones. So far, most
of the human gut microbiome (HGM) studies have been based on metagenomic
analysis. Here, we applied an analysis of individual HGM genomes to the identification
of ubiquinone and menaquinone biosynthetic pathways. In our opinion, the shift from
metagenomics to analysis of individual genomes is a pivotal milestone in investigation
of bacterial communities, including the HGM. The key results of this study are as
follows. (i) The distribution of the canonical pathways in the HGM genomes was
consistent with previous reports and with the distribution of the quinone-dependent
reductases for electron acceptors. (ii) The comparative genomics analysis identified
four alternative forms of the previously known enzymes for quinone biosynthesis. (iii)
Genes for the previously unknown part of the futalosine pathway were identified, and the
corresponding biochemical reactions were proposed. We discuss the remaining gaps in
the menaquinone and ubiquinone pathways in some of the microbes, which indicate the
existence of further alternate genes or routes. Together, these findings provide further
insight into the biosynthesis of quinones in bacteria and the physiology of the HGM.
Keywords: human gut microbiome, comparative genomics, quinone biosynthesis, non-orthologous
displacements, energy production
INTRODUCTION
Quinones are membrane lipid-soluble carriers of electrons that are essential for cellular respiration
(Collins and Jones, 1981). Of the numerous types of quinones used for respiration, the three that
are the most studied and most widespread among microorganisms are ubiquinone (UQ, coenzyme
Q), menaquinone (MK, vitamin K), and 2-demethylmenaquinone (DMK) (Collins and Jones, 1981;
Nowicka and Kruk, 2010). In bacteria, only one pathway has been described for UQ biosynthesis
(Meganathan, 2001b), whereas two different pathways are known for MK synthesis (Figure 1). The
first “traditional” pathway includes DMK as an immediate precursor of MK, and both MK and
DMK are synthesized via this pathway (Bentley and Meganathan, 1982; Meganathan, 2001a). In
the second pathway, which was more recently discovered, MK is synthesized through futalosine
(Hiratsuka et al., 2008). The final steps of this pathway remain unclear, and no information is
available about the synthesis of DMK by this pathway (Arakawa et al., 2011; Barta et al., 2014;
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FIGURE 1 | Pathways for UQ, MK, and DMK biosynthesis in the analyzed genomes. The names of relevant enzymes are shown for each reaction. Circled
numbers show the numbers of genomes in which genes for the corresponding enzyme were found. Solid arrows correspond to previously known enzymes, and
dashed arrows together with italicized enzyme names correspond to enzymes predicted in the current work. Because the products of the reactions catalyzed by
MenL and MenP are unknown, two possible variants of the pathway are shown. Abbreviations: Met, L-methionine; SAH, S-Adenosyl-L-homocysteine; SAM,
S-adenosyl-L-methionine.
Zhi et al., 2014). UQ can be synthesized by Alpha-, Beta-, and
Gammaproteobacteria and by Eukaryotes, whereas MK/DMK
can be synthesized only by various groups of Bacteria and
Archaea (Collins and Jones, 1981; Bentley andMeganathan, 1982;
Meganathan, 2001a; Nowicka and Kruk, 2010; Zhi et al., 2014).
All three pathways begin with chorismate and have no shared
enzymes except for the UbiE/MenG methyltransferase, which
is involved in both the UQ and the “traditional” MK/DMK
pathways (Lee et al., 1997; Figure 1).
Because of the inability of humans to synthesize MK, this
compound should be consumed in food. MK is found in meat,
dairy, and fermented food products (Walther et al., 2013).
MK can also be obtained by the interconversion of a dietary
derived phylloquinone (PK). PK is synthetized by plants and
Cyanobacteria and differs from MK only by its side chain. While
MK has a polyprenyl side chain, PK has a phytyl side chain
(Nowicka and Kruk, 2010). The extent of PK-derived MK has
been estimated to range from 5 to 25% of the digested PK
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(Shearer and Newman, 2008; Shearer et al., 2012). The dietary
requirements of vitamin K (i.e., PK and MK) range from 0.86 to
3.15µg per day for infants of 0–6 months (Canfield et al., 1990,
1991; Greer et al., 1991; Shearer and Newman, 2008) and from
0.75 to 1.0µg per kg of body mass per day for adults (Frick et al.,
1967; Booth and Al Rajabi, 2008; Shearer et al., 2012).
The classic role of MK in humans is as an enzyme cofactor
for the γ-carboxylation of peptide-bound glutamate residues, and
evidence has recently been mounting that there is a correlation
between human health and dietary MK (Shearer and Newman,
2008, 2014; Booth, 2009; Van Winckel et al., 2009; Walther et al.,
2013).
In addition to dietary sources, a portion of the total available
MK is synthesized by the human gut microbiome (HGM);
however, the extent of MK derived from the HGM has not
been determined (Ramotar et al., 1984; Conly and Stein, 1992;
Suttie, 1995; LeBlanc et al., 2013; Ramakrishna, 2013). Various
HGM communities have been intensively studied in recent
years (Eckburg et al., 2005; Gill et al., 2006; Sonnenburg
et al., 2006; Kinross et al., 2011; Flint et al., 2012; Lozupone
et al., 2012; Leimena et al., 2013; Maurice et al., 2013), but
most of these studies have concentrated on the analysis of
metagenomic data. Metagenomic analysis is a powerful tool
for the determination of HGM composition in healthy and
diseased states (Cowan et al., 2005; Kinross et al., 2011; Simon
and Daniel, 2011; Cho and Blaser, 2012; Gosalbes et al., 2012;
Kelly and Mulder, 2012; Walker et al., 2014) as well as HGM
variability related to age (Clemente et al., 2012; Yatsunenko
et al., 2012), diet (Kurokawa et al., 2007; Hehemann et al.,
2010; Wu et al., 2011), geography (Yatsunenko et al., 2012;
Tyakht et al., 2013; Suzuki and Worobey, 2014), host genetics,
and lifestyle (Yatsunenko et al., 2012). However, analysis of
the completely or partially assembled genomes of representative
HGM samples can also yield additional knowledge about the
cellular physiology of individual bacterial strains and information
about interactions between different organisms. Thus, a shift
from metagenomic analysis to the analysis of individual genome
sequences may become important in the investigation of the
HGM and its interactions with the human organism. To
date, there are 382 HGM genomes available through the
National Institutes of Health (NIH) Human Microbiome Project
(http://www.hmpdacc.org/HMRGD/), providing an excellent
opportunity for gaining a further understanding of HGM
biology.
MATERIALS AND METHODS
From the list of human gut microbes found in at least 50% of
the analyzed HGMs (Nelson et al., 2010; Qin et al., 2010), we
selected 250 genomes of human intestinal inhabitants that were
available in the PubSEED (Overbeek et al., 2005; Disz et al., 2010)
and Integrated Microbial Genomes (IMG) databases (Markowitz
et al., 2014). The following four model genomes were added to
the reference set: an inhabitant of the lower gut, Escherichia coli
K-12 MG1655 (Blattner et al., 1997); an intestinal inflammation-
causing agent, Salmonella enterica Typhimurium LT2 (Winter
et al., 2010); a model organism for the analysis of carbohydrate
metabolism in the intestine, Bacteroides thetaiotaomicron VPI-
5482 (Hooper et al., 2002; Xu et al., 2003); and a model organism
related to multiple gut strains, Bacillus subtilis 168 (Hong et al.,
2009). All 254 of the selected genomes are presented in Table S1
in Supplementary Materials. The added model organisms belong
to the three main phyla represented in HGM (Nelson et al., 2010;
Qin et al., 2010), Bacteroidetes (B. thetaiotaomicron), Firmicutes
(B. subtilis), and Proteobacteria (E. coli and S. enterica). We
included of the model organisms to expand known metabolic
functions in these organisms to the HGM genomes as well as to
use their predictions as mean to quality control the predictions
for the HGM genomes. For example, usage of genomes for the
model organisms can be used to avoid wrong predictions for
the functions of novel genes by verifying their absence in the
model genomes. Note that three of the four model organisms (B.
thetaiotaomicron, E. coli, and S. enterica) have been also detected
in HGM, but in less than 50% of the studied samples (Qin et al.,
2010).
The PubSEED platform was used to annotate the genes
for quinone biosynthesis proteins. To avoid misannotations,
all of the proteins with the same function were checked for
orthology. Orthologs were defined as the best bidirectional hits
that have a similar genomic context. To search for the best
bidirectional hits, a BLAST algorithm (Altschul et al., 1997)
implemented in PubSEED and the IMG platform was used
(cutoff = e−20). Additionally, in the search for orthologs, the
GenomeExplorer program package (Mironov et al., 2000) was
used, and orthologs were determined as the best bidirectional
hits with protein identity no less than 20%. To analyze genomic
context and gene occurrence, we used PubSEED and STRING
v9.1 (Franceschini et al., 2013) along with phylogenetic trees
for protein domains in MicrobesOnline (Dehal et al., 2010).
To analyze protein domain structure, we used searches in the
Pfam (Finn et al., 2014) and CDD (Marchler-Bauer et al.,
2013) databases, and the “Domains and Families” service
implemented in the MicrobesOnline platform. Additionally,
functional annotations of the analyzed genes were performed
using the UniProt (Magrane and Consortium, 2011) and KEGG
(Kanehisa et al., 2012) databases.
Multiple protein alignments were performed using the
ClustalX v 2.0 tool (protein weight matrix: BLOSUM series;
gap opening: 15; gap extension: 0.5) (Larkin et al., 2007).
Phylogenetic trees were constructed using the maximum-
likelihood method with the default parameters implemented
in PhyML-3.0 (Guindon et al., 2010). The obtained trees were
visualized and midpoint-rooted using the interactive viewer
Dendroscope, version 3.2.10, build 19 (Huson et al., 2007).
To clarify the taxonomic affiliations of the analyzed genomes,
the NCBI Taxonomy database (http://www.ncbi.nlm.nih.gov/
taxonomy) was used. To predict substrate specificities according
to the specificity-determining positions (SDP), the SDPfox web
tool (Mazin et al., 2010) was used with the maximum percent
of gaps allowed in a group in each column being 50%. As an
input for the SDP analysis, we used multiple alignments for all
UbiA/MqnP, UbiD/MqnL, and UbiX/MqnM proteins found in
the analyzed genomes. No preliminary division to into specific
groups was done. The specificity groups were determined based
Frontiers in Microbiology | www.frontiersin.org 3 February 2016 | Volume 7 | Article 128
Ravcheev and Thiele Quinone Biosynthesis in the Human Gut Microbiota
on the SDP analysis as follows. An uploaded aligned sequence set
was randomly divided into groups (the minimal number of the
groups= 2, the number of the sequences= 10), then “SPDgroup”
procedure and the “Move sequences according to the best weight”
procedure were applied.
All of the annotated genes are represented as a subsystem
in PubSEED (http://pubseed.theseed.org/SubsysEditor.cgi?
page=ShowSubsystem&subsystem=Quinones_biosynthesis_
HGM) and all of the protein sequences for the annotated genes
in FASTA format are represented in file Sequences S1 in the
Supplementary Materials.
RESULTS
Here, we present a systematic analysis of the biosynthetic
pathways for UQ, MK, and DMK in 254 genomes, including
250 genomes for commonly found in the human gut (Qin et al.,
2010) and four genomes for model organisms. Application of
a comparative genomic analysis to individual HGM genomes
identified the distribution of various pathways for quinone
biosynthesis in HGM microorganisms and revealed four
alternative forms of known enzymes in these pathways. Our
analysis resulted in a prediction of the genes responsible for the
last three steps of the futalosine biosynthesis pathway, which were
previously unknown. Additionally, we compared the distribution
of quinone biosynthetic pathways with the distribution of
quinone-dependent reductases for electron acceptors within the
HGM genomes.
Known Genes for Quinone Biosynthesis
To reconstruct the biosynthetic pathways of UQ, MK, and DMK
in the 254 studied genomes, we analyzed the distribution of
previously known genes involved in these pathways (Figure 1).
On the basis of the presence of known genes, a pathway can be
classified as complete or incomplete. A pathway was assigned
as complete when known genes found in the genome could
form an uninterrupted biosynthetic pathway from chorismate
to UQ or MK and as incomplete when the pathway was
interrupted because of the absence of certain genes. The presence
of only one gene was classified as an incomplete pathway. To
avoid misannotations, all genes possibly involved in quinone
biosynthesis were checked for orthology with the known genes,
as described in “Experimental procedures.” The distribution of
the genes for UQ biosynthesis (Ubi pathway) among the analyzed
genomes was restricted to Gamma- and Betaproteobacteria.
Complete Ubi pathways were found in 19 genomes (Table S1
in Supplementary Materials), whereas incomplete pathways were
found in 4 genomes. The pathway for MK/DMK biosynthesis
through O-succinylbenzoate (Men pathway) was more broadly
distributed among the analyzed genomes. Complete Men
pathways were found in 24 genomes of Firmicutes and
Proteobacteria, whereas incomplete pathways were found in 91
genomes belonging to the phyla Actinobacteria, Bacteroidetes,
Firmicutes, Fusobacteria, Proteobacteria, and Verrucomicrobia.
Because the enzymes for the last steps of MK synthesis through
the futalosine biosynthesis pathway (Mqn pathway) were not
known (Arakawa et al., 2011; Barta et al., 2014; Zhi et al., 2014),
this pathway was considered complete when all of the enzymes
catalyzing the reactions for the synthesis of 1,4-dihydroxy-
6-naphthoate from chorismate (Figure 1) were found in the
genome. The complete pathway was found in 10 genomes
from the phyla Bacteroidetes, Firmicutes, and Proteobacteria,
whereas an incomplete pathway was found in 2 Firmicutes
genomes.
Novel Enzyme in the Ubi Pathway
Using genomic analysis of the Ubi pathway, we predicted an
alternative form of 3-polyprenyl-4-hydroxybenzoate carboxy-
lyase (EC 4.1.1.-) (Figure 2). Previously, two alternative forms
of this enzyme, UbiD and UbiX, were described (Cox et al.,
1969; Alexander and Young, 1978; Gulmezian et al., 2007).
Analysis of the genome of Acinetobacter junii SH205 revealed
the presence of all the genes for the Ubi pathway except for
ubiD and ubiX. To find a non-orthologous replacement (Koonin
et al., 1996) for this enzyme, we searched for ubiD and ubiX
orthologs in the genomes of organisms related to A. junii
(Figure 2). These genomes belonged to two families of the order
Pseudomonadales: Moraxellaceae (which includes A. junii) and
Pseudomonadaceae. Orthologs of Escherichia coli K-12 MG1655
ubiD (e ≤ 9e−54, identity ≥ 86%) and ubiX (e ≤ 3e−60,
identity ≥ 54%) were found in Pseudomonadaceae but not in
the Moraxellaceae genomes. Thus, the Moraxellaceae genomes
should encode an alternative 3-polyprenyl-4-hydroxybenzoate
carboxy-lyase that is non-orthologous to ubiD or ubiX, and
this alternative gene should be present in Moraxellaceae but
not in Pseudomonadaceae. Analysis of gene occurrence by IMG
revealed 29 candidates. A hypothetical protein (the locus tag
in A. junii is HMPREF0026_02430), was considered to be the
most probable candidate because of its co-localization on the
chromosome with the ubiE and ubiB genes in the genomes of
Acinetobacter spp. and Psychrobacter sp. PRwf-1. We named this
gene ubiZ. The number of genomes with a complete Ubi pathway
thus increased from 19 to 20.
Novel Enzymes in the Men Pathway
We predicted alternative genes for 1,4-dihydroxy-2-naphthoyl-
CoA thioesterase (EC 3.1.2.28) and for (1R,6R)-2-succinyl-
6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (EC
4.2.99.20) (Figure 2). The first enzyme is typically encoded
by the menI gene (Widhalm et al., 2009; Chen et al., 2013),
whereas the second enzyme is typically encoded by the menH
gene (Jiang et al., 2007, 2008). No menI orthologs were found
in the genomes of Eggerthella sp. 1_3_56FAA or Gordonibacter
pamelaeae 7-10-1-b. A sequence similarity search using the
tblastn algorithm (Altschul et al., 1997) revealed in these
genomes a distantly related homolog ofmenI (e = 1.4, identity=
30%, the locus tag in G. pamelaeae is GPA_07290) that was
annotated as a hypothetical protein. Because such an e-value
and identity is not significant, we verified the presence of this
protein in the analyzed genomes. The orthologs of this new
gene were found only in genomes having the Men pathway
but lacking menI. Consequently, we propose that this gene,
called menJ, could replace the function of menI. There are no
additional corroborations for this prediction, such as a genomic
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FIGURE 2 | Non-orthologous replacements and novel genes in quinone biosynthesis pathways. (A) Model organisms; (B) examples of genomes with
predicted non-orthologous replacements and novel genes; (C) legend.
location with other MK synthesis genes or a sequence similarity
to functionally relevant proteins. Hence, this prediction remains
quite speculative.
A non-orthologous replacement for the menH gene was
predicted by a detailed analysis of the menI genes in the
studied genomes. This analysis revealed two types of MenI
proteins. The first type has the same domain structure as a
protein from E. coli and includes a single thioesterase domain
(Pfam ID: PF03061). The second type of MenI has the same
PF03061 domain at its C-terminus and an additional hydrolase
domain (Pfam ID: PF08282) at its N-terminus (Figure S1A
in Supplementary Materials). The PF08292 domain belongs to
the haloacid dehydrogenase superfamily, the members of which
catalyze reactions similar to the one catalyzed by MenH (Koonin
and Tatusov, 1994). In the analyzed genomes, we observed
two types of orthologs containing the PF08282 domain: the
PF08282-MenI fusions and proteins having a single PF08282
domain (Figure S1B in Supplementary Materials). All the
proteins that contained a PF08282 domain were present only
in genomes lacking the MenH orthologs. Thus, the PF08282-
domain protein, called MenY, was proposed to be a non-
orthologous displacement for MenH. The prediction of themenJ
and menY genes increased the number of genomes with a
complete Men pathway from 24 to 72.
Novel Enzyme in the Mqn Pathway
Using a genomic analysis of the Mqn pathway, we predicted
an alternative form of 1,4-dihydroxy-6-naphthoate synthase
(EC 1.14.-.-) and proposed an enzyme for the previously
unknown steps of this pathway. In the genomes of Mitsuokella
multacida DSM 20544 and Megamonas hypermegale ART12/1,
no mqnD genes were found, but we detected a gene that
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co-localized together with the mqnC and mqnE genes (the
locus tag in M. hypermegale is MHY_27640). In addition to
M. multacida and M. hypermegale, this protein was found to
cluster with themqnC andmqnE genes in six genomes, including
Selenomonas artemidis F0399, Selenomonas flueggeiATCC 43531,
Selenomonas noxia ATCC 43541, Selenomonas sp. 67H29BP,
Selenomonas sp. F0430, and Selenomonas sputigenaATCC 35185.
In further four genomes, Pelotomaculum thermopropionicum
SI, Syntrophomonas wolfei str. Goettingen, Syntrophothermus
lipocalidus DSM 12680, and Thermosinus carboxydivorans, this
protein was found to co-localize with the mqnEAC operon.
Because this gene was found only in conjunction with the
other genes in this pathway but not with mqnD, we proposed
that this gene (mqnZ) can replace the gene function of mqnD.
Unfortunately, sequence analysis of this protein did not provide
additional support for its prediction as the only sequence
similarity was found with the phosphorylase superfamily (Pfam
ID: PF01048) (e = 1.14e−32).
Prediction of the Last Steps of the Mqn
Pathway
Previously, it has been proposed that the final biosynthetic
stages of the Mqn pathway should be catalyzed by a
polyprenyltransferase, a carboxy-lyase, and a methyltransferase
(Arakawa et al., 2011; Barta et al., 2014; Zhi et al., 2014), but
the particular enzymes are unknown. Analysis of genomes
containing genes for the Mqn pathway revealed genes that
are homologous to ubiE/menG, ubiA, ubiD, and ubiX. The
UbiE/MenG proteins encode S-adenosyl-L-methionine-
dependent methyltransferases that transfer a methyl group to
the carbon atom of the aromatic ring, which is part of both
UQ and MQ. These methyltransferases are involved in both
the Ubi and Men pathways (Lee et al., 1997). Thus, we propose
that the Mqn co-occurring homologs of UbiE/MenG could be
involved in menaquinone synthesis. To test this hypothesis, we
constructed a phylogenetic tree for the UbiE/MenG-like proteins
co-occurring with the Ubi, Men, andMqn pathways (Figure S2 in
Supplementary Materials). The Mqn co-occurring proteins did
not form a separate monophyletic branch but were mixed with
the Men co-occurring proteins. Based on this co-occurrence, we
propose that the Mqn co-occurring UbiE/MenG proteins play
the same role as UbiE/MenG, i.e., catalyzing the methylation of
DMK to produce MK.
The UbiA protein catalyzes the attachment of a polyprenyl
group to the quinone aromatic ring (Melzer and Heide, 1994).
We propose that the Mqn co-occurring homologs of UbiA are
involved in the Mqn pathway. On the other hand, in the Mqn
pathway a polyprenyl group could be attached to 1,4-dihydroxy-
6-naphthoate or its derivatives, whereas UbiA catalyzes the
attachment of a polyprenyl group to 4-hydroxybenzoate.
Thus, different substrate specificities of UbiA and its Mqn
co-occurring homologs could correlate with distinguishable
differences on the amino acid sequence level. Correlations
between phylogeny and substrate specificity have been reported
for various enzymes (Lee et al., 2007; Olivares-Hernández et al.,
2010; Reddy et al., 2013; Ratnikov et al., 2014). Consequently,
we proposed that UbiA and its Mqn co-occurring homolog
form a clearly distinguished branches in their phylogenetical
tree. To test this hypothesis, we constructed a phylogenetic
tree (Figure S3 in Supplementary Materials) for the three
homolog groups: (1) UbiA proteins, (2) the Mqn co-occurring
homologs of UbiA, and (3) MenA proteins. Each group in
the tree formed a monophyletic branch. The UbiA proteins
and the Mqn co-occurring homologs of UbiA (named MqnP)
branches were neighboring but were clearly separated from each
other. Thus, we propose that UbiA and MqnP have similar
functions but have different substrate specificities. The MqnP
protein is proposed to be a polyprenyltransferase in the Mqn
pathway.
The UbiD and UbiX proteins are carboxy-lyases in the
Ubi pathway (Cox et al., 1969; Alexander and Young, 1978;
Gulmezian et al., 2007). Homologs for both of these proteins were
found in the genomes encoding enzymes for the Mqn pathway.
As for the UbiA homologs, we suspected that the Ubi pathway
proteins and their Mqn co-occurring homologs would have
different substrate specificities and would be clearly separated
based on the corresponding phylogenetic trees. Construction of
such trees (Figure S4A in Supplementary Materials) confirmed
this proposition. The UbiD proteins and their Mqn co-occurring
homologs formed monophyletic branches that were clearly
separated from each other. The same was true for the UbiX
proteins and their Mqn co-occurring homologs (Figure S4B in
Supplementary Materials). Based on these results, we propose
that the Mqn co-occurring homologs of UbiD and UbiX are
carboxy-lyases in the Mqn pathway; we named them MqnL and
MqnM, respectively.
Additionally, the presence of SDPs (Kalinina et al., 2004;
Mazin et al., 2010) was analyzed for the UbiA/MqnP,
UbiD/MqnL, and UbiX/MqnM proteins were found in the
HGM genomes. For each of these groups of homologous, 33,
27, and 7 SDPs were determined, respectively (Figure S5 in
Supplementary Materials). After grouping by determined SDPs
(see “Materials and Methods” for details), each set of homologs
was divided to two groups. In all three groups of homologs,
SDPs-based groups turned out to be in agreement with the
division of phylogenetic trees and our predictions of functions.
Thus, the enzymes for all three steps (polyprenylation,
decarboxylation, and methylation) in the transformation of
1,4-dihydroxy-6-naphthoate into MK were predicted. However,
the order of these steps is not completely clear. Because the
Mqn pathway associated with UbiE/MenG was indistinguishable
from the Men pathway, we propose that methylation may
be the final step of the Mqn pathway, as is the case
for the Men pathway. For the ordering of polyprenylation
and decarboxylation, we propose two alternative scenarios
(Figure 1). In the first scenario, 1,4-dihydroxy-6-naphthoate is
initially polyprenylated to form 3-polyprenyl-1,4-dihydroxy-6-
naphthoate, which then is decarboxylated to DMK. In the second
scenario, 1,4-dihydroxy-6-naphthoate is initially decarboxylated
to form naphthoquinone, which could then be polyprenylated to
formDMK. ThemqnP,mqnL, andmqnM genes were all found in
each genome containing the Mqn pathway, but these genes were
absent in the other genomes, supporting our predictions of their
involvement in the Mqn pathway.
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Co-distribution of Quinone Biosynthetic
Pathways and Quinone-Dependent
Reductases for Electron Acceptors
Based on the presence of the Ubi, Men, and Mqn pathways
in each analyzed genome, we predicted the patterns of the
synthesized quinones. The ability to synthesize UQ is directly
determined by the presence of the Ubi pathway, whereas the
situation for DMK and MK synthesis is more complicated.
Because DMK is an intermediate in the Men and Mqn pathways,
organisms with genomes having one of these pathways should be
able to synthesize DMK. The ability to synthesizeMK depends on
the presence of the ubiE/menG genes. In the presence of the Men
or Mqn pathway, having ubiE/menG in the genome determines
the ability to synthesize both MK and DMK. Meanwhile, the
presence of the Men or Mqn pathway without ubiE/menG in
the genome results in the synthesis of DMK only. Overall, five
different patterns of quinone synthesis were found (Table S2 in
Supplementary Materials). A total of 19 genomes were able to
synthesize UQ,MK, andDMK, 4 genomes were able to synthesize
UQ only, 99 genomes were able to synthesize MK and DMK,
8 genomes were able to synthesize DMK only, and, finally, 124
genomes were not able to synthesize any of the quinones.
The distribution of quinone synthesis patterns in the HGM
genomes was also compared to the distribution patterns
of quinone-dependent reductases for electron acceptors (also
referred to as reductases) obtained from a previous analysis of
HGM genomes (Ravcheev and Thiele, 2014). Only quinone-
interacting reductases were included in our analysis. A reductase
was considered as quinone-interacting if orthologs of known
quinone-interacting subunits were found in chromosomal gene
cluster encoding for this reductase. In total, we analyzed
17 types of reductases with the following electron acceptors:
oxygen (Cyo, Qox, and Cyd), nitrate (Nar and Nap), nitrite
(Nrf), tetrathionate (Ttr), thiosulfate (Phs and Tsr), sulfite
(Dsr), polysulfite (Psr), trimethylamine N-oxide (Tor), dimethyl
sulfoxide (Dms), selenate (Ynf), fumarate (Frd), and arsenate
(Arx), as well as the Ynf reductase with unknown specificity.
Overall, orthologs of 23 quinone-interacting membrane subunits
were found in the analyzed genomes. For 14 of these membrane
subunits, interactions with quinones have been confirmed
experimentally, whereas for the 6 proteins interactions with
quinones have been previously predicted based on similarity with
known quinone-interacting subunits. For the remaining three
proteins, TsrF, DmsH, and YdhD, interactions with quinones
were predicted in this study based on sequence similarity with the
experimentally validated quinone-interacting NrfD protein from
E. coli (Table S3 in Supplementary Materials).
Of the 254 genomes, 225 (88.6%) genomes demonstrated
good agreement between the distributions of reductases and
quinones (Figure 3 and Table S2 in Supplementary Materials):
121 genomes (47.6%) encoded both reductases and quinone-
synthesis pathways, whereas the remaining 104 genomes (40.9%)
encoded neither reductases nor quinone-synthesis pathways. The
remaining 29 genomes (11.4%) disagreed in their distributions
of quinone-synthesis pathways and reductases. In 20 genomes
(7.9%), reductases were identified but no quinone biosynthetic
FIGURE 3 | Co-distribution of quinone biosynthetic pathways and
quinone-dependent reductases for electron acceptors. The number of
genomes is shown. Inconsistencies between the reductase and quinone
patterns are indicated by ellipses. TMAO, trimethylamine N-oxide; DMSO,
dimethyl sulfoxide.
pathways were found. Finally, 9 genomes (3.5%) encoded
pathways able to synthesize at least one quinone but contained
no identified reductases.
DISCUSSION
In this study, we analyzed the distribution of three pathways
for the biosynthesis of respiratory quinones in 254 genomes,
including 250 genomes for microbes commonly found in the
healthy human gut and four genomes for model organisms.
Our key results are as follows. (i) The HGM distribution of
canonical pathways was consistent with previous reports and
with the distribution of reductases for electron acceptors. (ii) A
comparative genomics analysis identified four alternative forms
of the previously known enzymes for quinone biosynthesis. (iii)
Genes for a previously unknown part of the futalosine pathway
were identified, and the corresponding biochemical reactions,
enzymes, and genes were proposed. Furthermore, we discuss the
remaining gaps in some of the genomes.
The distributions of the three studied quinone biosynthesis
pathways in the HGM correspond to previous data on the
distribution of these pathways (Collins and Jones, 1981; Nowicka
and Kruk, 2010). For instance, the Men pathway has been
previously shown to be more frequent among Prokaryotes (Zhi
et al., 2014). This observation corresponds to the presence of this
pathway in almost half of the analyzed genomes. In comparison,
the Ubi and Mqn pathways are present in 9 and 5% of the
studied genomes, respectively. Additionally, only Alpha-, Beta-,
and Gammaproteobacteria synthesize UQ (Meganathan, 2001b;
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Cluis et al., 2012). Indeed, among the studied genomes, the
UQ biosynthetic genes were not found to be absent in any of
analyzed Beta- orGammaproteobacteria (no Alphaproteobacteria
genomes were analyzed in this work). Two-thirds of the studied
genomes belong to genera for which experimental data on the
production of respiratory quinones is available (Table S4 in
Supplementary Materials). The predictions from the genomic
analysis were consistent with the experimental data for all
HGM genomes. A similar concordance was observed when the
distributions of quinone biosynthetic pathways and of quinone-
dependent reductases for electron acceptors were compared
(Figure 3). For instance, the genes for the UQ-interacting aerobic
reductase complex CyoABCD (Abramson et al., 2000) were
found only in genomes encoding the UQ biosynthetic pathway.
Additionally, anaerobic reductases for tetrathionate, thiosulfate,
polysulfide, sulfite, fumarate, trimethylamine N-oxide, dimethyl
sulfoxide, selenate, and arsenate were found exclusively in the
genomes encoding the MK/DMK biosynthetic pathways, but not
in genomes having only the UQ or DMK biosynthetic pathways.
A comparative genomics approach can thus be used to accurately
annotate quinone biosynthetic pathways.
Comparative genomic analysis of the quinone biosynthetic
pathways revealed four non-orthologous replacements for
previously known enzymes. A total of four alternative enzymes
were predicted: one for the Ubi pathway, two for the Men
Pathway, and one for the Mqn pathway. These predictions were
made possible by analysis of multiple genome sequences and by
the use of multiple comparative genomics methods. For example,
the prediction of MenY, a non-orthologous replacement for the
previously known protein MenH, is based on the following
assumptions. (1) The MenY protein belongs to the superfamily
of HAD hydrolases, i.e., its general function is relevant. (2) The
MenY protein forms protein fusions (multi-domain proteins)
with the MenI protein. (3) The menY gene is co-located on the
chromosome with other men genes in the 31 studied genomes.
(4) ThemenY gene is present only in genomes that lack themenH
gene. Each of these assumptions alone is not enough to confirm
the prediction that MenY is a MenH-replacing enzyme, but
collectively, they provide a sufficient basis for such a prediction.
Thus, the combinatorial use of multiple methods can increase
the impact of genome-based predictions. Additionally, the use of
comparative genomics for the prediction of alternative enzyme
forms provides a good basis for further experimental validation.
The most notable result of this work is the prediction
of previously unknown stages of the futalosine pathway and
of genes encoding the corresponding enzymes: mqnP, mqnL,
and mqnM (Figure 1). This prediction was permitted by the
application of multiple genomic techniques to large numbers of
analyzed genomes. Further experimental verification is required
to confirm the validity of this prediction. This re-annotation also
resolves the incomplete Ubi pathway in a number of genomes
outside of Alpha-, Beta-, and Gammaproteobacteria, making the
annotation consistent with data on the taxonomic distribution of
this pathway (Meganathan, 2001b; Cluis et al., 2012).
The detection of enzymes for previously unknown stages of
the Mqn pathway increases our knowledge of the evolutionary
history of the quinone biosynthetic pathways. The Mqn
pathway was shown to be the primordial pathway for the
MK biosynthesis, whereas the Men pathway appeared later in
evolution (Zhi et al., 2014). The narrow taxonomic distribution
of the Ubi pathway clearly indicates that it is the most
recently evolved pathway. The results of the current work
specify the details of pathway evolution. Quinone biosynthetic
pathways that newly emerge during evolution may use parts
of preexisting pathways. Thus, the Men pathway adopted a
methyltransferase and, because the MenA is a homolog of the
MqnP, possibly a polyprenyltransferase from the more ancient
Mqn pathway. The Ubi pathway, the youngest of the three
studied pathways, adopted three proteins from theMqn pathway:
polyprenyltransferase and two non-homologous carboxy-lyases.
Additionally, the Ubi pathway adopted a methyltransferase from
the Mqn or Men pathway. Thus, younger pathways contain
more enzymes adopted from older pathways. This assumption
is based on only the three analyzed pathways and is therefore
quite speculative. Nonetheless, this assumption can lead to an
interesting conclusion. For example, the alternative isoprenoid
quinones, such as sulfolobusquinone, caldariellaquinone, and
benzodithiophenoquinone, have a very narrow taxonomic
distribution (Nowicka and Kruk, 2010; Zhi et al., 2014), and
their biosynthetic pathways should be younger than the Men
and Mqn pathways. The pathway for the biosynthesis of the
alternative quinones would thus be expected to contain homologs
of enzymes from more ancient pathways. This expectation could
be used to predict such pathways. Of course, such predictions
will also be quite speculative and will require experimental
validation. However, if this assumption is true, it can be used
for the prediction of various novel pathways beyond quinone
biosynthesis.
FURTHER DIRECTIONS
Our study resulted in the functional predictions for a number
of genes involved in quinone biosynthesis. Such predictions
illustrate the power of comparative analysis of individual
genomes. Nonetheless, some problems related to microbial
quinone biosynthesis still remain unresolved. The first problem is
the presence of incomplete biosynthesis pathways. For instance,
incompleteMen pathways were found in 43 genomes. Three non-
exclusive hypotheses might explain this pathway incompleteness:
(1) the incompleteness of genome sequences, (2) inter-microbe
exchange of metabolites, and (3) non-orthologous replacements.
Two-thirds of the analyzed genomes have a draft status, and
some genes for the quinone biosynthetic pathways may thus be
absent from the current version of the genome. Completion of
the sequences of current draft genomes may complete the Men
pathway. For example, the draft genome sequence of Escherichia
sp. 1_1_43 lacks genes for the Men pathway and lacks some
genes in the Ubi pathway (Table S1 in Supplementary Materials).
Nevertheless, in all the complete genomes of Escherichia spp., all
the genes for these two pathways were found. Thus, we can be
confident that the quinone biosynthesis genes missing from the
current genome of Escherichia sp. 1_1_43 will be detected in the
finished version of this genome. Thus, the first further direction
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is an update of the study results using a novel, complete version
of previously incomplete genomes.
The availability of finished genomes for all the studied
organisms will only partially resolve the problem of pathway
incompleteness, as incomplete pathways were also found
in a number of finished genomes (Figure 4). For example,
the multiple finished genomes of Lactobacillus spp. showed
incomplete Men pathways. The common feature of these
incomplete pathways is that early steps of the pathway are
missing whereas late steps are present, at least the steps required
for the polyprenylation and methylation catalyzed by MenA
and MenG, respectively (Figure 4). Because the addition of a
hydrophobic polyprenyl group takes place at the penultimate
step of the Men pathway, all MK precursors from isochorismate
to 1,4-dihydroxy-2-naphthoate are soluble; thus, exchange of
these metabolites between different microorganisms could be
possible. For example, 1,4-dihydroxy-2-naphthoate could be
used by microbes having only the menAG genes, whereas
O-succinylbenzoate could be used by microbes having the
menEBIAG genes. We hypothesize that such organisms could
utilize soluble precursors of MK. Hence, the corresponding
transport genes should be present in their genomes, but
remain to be annotated. Two types of transporters would be
required, (1) transporters for the export of soluble quinone
precursors in the producing organisms and (2) transporters for
the import of these precursors in the consuming organisms.
Whereas nothing is known about the exchange of quinone
precursors in microbial communities, inter-species exchange
of metabolites has been demonstrated for the HGM. For
instance, HGM organisms can exchange acetate, extracellular
polysaccharides, formate, fucose, molecular hydrogen, secondary
bile acids, short-chain fatty acids, sialic acid, and succinate
(Stams and Plugge, 2009; De Vuyst and Leroy, 2011; Ng
et al., 2013; Kovács, 2014; Vogt et al., 2015). Thus, the
proposed exchange of soluble quinone precursors is very
likely.
The hypothesis that MK precursors may be exchanged
between microbes is tempting but remains speculative. To
confirm this hypothesis, the transporters of the corresponding
MK precursors must be computationally predicted and then
experimentally validated. For better support of the exchange
hypothesis, co-presence of the producing and consuming
organisms in various HGM samples would need to be
analyzed. These inter-microbe interactions should also be
validated experimentally and/or tested computationally using the
mathematical models (see below).
Even if the exchange hypothesis were true, the problem
of incomplete pathways could not be sufficiently resolved.
In some finished genomes, such as Akkermansia muciniphila
or Megamonas hypermegale, the pathways lack internal steps
(Figure 4). For these genomes, an important next step would
be the search for non-orthologous replacements in incomplete
pathways. Non-orthologous replacements are well known for
quinone biosynthetic pathways. For example, in E. coli, the
decarboxylation of 3-polyprenyl-4-hydroxybenzoate can be
catalyzed by two non-homologous proteins, UbiD and UbiX
(Cox et al., 1969; Alexander and Young, 1978; Gulmezian
et al., 2007). Another example is the existence of multiple non-
orthologous replacements for enzymes catalyzing the early steps
of the Mqn pathway (Arakawa et al., 2011). Additionally, four
non-orthologous replacements were predicted in this study.
The non-orthologous replacement hypothesis is very promising
because these replacements can be successfully determined even
using computational methods alone. If such replacements are
found, the problem of pathway incompleteness could be resolved.
The other unresolved problem is the inconsistency between
the distributions of quinone biosynthetic pathways and quinone-
dependent reductases for electron acceptors (Figure 3). Two
FIGURE 4 | Incompleteness or loss of quinone biosynthetic pathways in the finished genomes.
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main types of inconsistencies were observed: (1) absence of
reductases in the presence of quinone biosynthetic pathways and
(2) absence of quinone biosynthetic pathways in the presence of
reductases. Of course, both of these problems may be partially
resolved by the availability of finished genomes. On the other
hand, such inconsistencies were also found in finished genomes
(Table S1 in SupplementaryMaterials). The absence of reductases
could be explained by the use of unknown reductases by an
organism. In a previous study, we have predicted two novel
membrane reductases among HGM genomes (Ravcheev and
Thiele, 2014), and at least one of them, thiosulfate reductase Tsr,
was predicted as quinone-dependent (Table S3 in Supplementary
Materials). Further systematic analysis of respiratory enzymes in
the HGM genomes could resolve this type of inconsistencies.
The absence of quinone biosynthetic pathways could be
explained by the existence of alternative quinone biosynthetic
pathways. For instance, the alternative Mqn pathway for MK
biosynthesis has been discovered in 2008 (Hiratsuka et al., 2008).
Additionally, alternative types of quinones may be used for
respiration in organisms having reductases but lacking the Ubi,
Men, and Mqn pathways. In this study, we limited our analysis
to the biosynthesis of UQ, MK, and DMK, but the diversity of
microbial respiratory quinones is much wider (Collins and Jones,
1981; Nowicka and Kruk, 2010). Nonetheless, the biosynthetic
pathways of alternative quinones are poorly understood. We
anticipate that increasing wealth of experimental and genomic
data will substantially improve our understanding of these
pathways.
In this study, the non-orthologous displacements and genes
for previously unknown reactions were only computationally
predicted; thus requiring experimental confirmation. For
example, the predicted 2-succinyl-5-enolpyruvyl-6-hydroxy-
3-cyclohexene-1-carboxylate dehydrogenase MenY could be
verified using model organisms, such as Corynebacterium spp. or
Bacteroides spp. Similarly, the novel enzymes in theMqn pathway
could be experimentally analyzed using Helicobacter spp.
Furthermore, the respiratory systems in the HGM organisms
are not limited to reductases and quinones. For broader coverage
of the respiratory systems, our study will need to be extended to
the analysis of ATP synthases and dehydrogenases for electron
donors. Other pathways of relevance to human health, such as
the B-vitamin synthesis capability of the HGM (Magnúsdóttir
et al., 2015), should be also considered. The identification of novel
enzymes and pathways will lead to better understanding of the
HGM biochemistry and physiology. This is a pre-requisite to
understand the HGM’s contribution to human health and disease
as well as to rationally alter HGM. Current approaches aiming
to modify the HGM, such as fecal transplants (Kelly et al., 2015)
and probiotics, lack mechanistic bases, which is partially due to
insufficient biochemical knowledge.
The quinone biosynthesis needs also to be analyzed in the
context human-microbe interactions. An inability of human
cells to synthetize MK, together with the importance of this
compound for the human health (Shearer and Newman, 2008,
2014; Booth, 2009; VanWinckel et al., 2009; Walther et al., 2013),
raises the question about a role of gut microbiota in the MK
supply of the host. So far, MK biosynthesis has been studied
in monocultures of model organisms (Bentley and Meganathan,
1982; Ramotar et al., 1984; Fernandez and Collins, 1987; Walther
et al., 2013) or in animal-microbe models (Kindberg et al.,
1987; Davidson et al., 1998) but the information about the
human-microbe exchange of MK is still very scarce. Nonetheless,
rat models demonstrated that luminal concentrations of MK
produced by Escherichia coli and Bacteroides vulgatus could reach
6–7 and 8µg per g of dry feces, respectively. Assuming a similar
ratio for humans and a daily fecal output of 25-50 g solid matter
in healthy individuals (Wyman et al., 1978), microbial produced
and excreted MK could range from 150 to 400µg feces. The
recommended dietary intake of vitamin K, of which MK is
a minor part, is for sucking infants 0.86–3.15µg per day for
sucking infants (Canfield et al., 1990, 1991; Greer et al., 1991;
Shearer and Newman, 2008) and for adults 75–90µg per day
(Frick et al., 1967; Booth and Al Rajabi, 2008; Shearer et al., 2012).
In fact, the microbial contribution to MK requirements has been
suggested to be approximately 50% (Wyman et al., 1978), but
evidence is still missing.
Computational modeling (Palsson, 2006; Orth et al., 2010)
of HGM metabolism could be used to systematically elucidate
the MK biosynthesis potential of different HGM representatives.
In fact, genome-scale metabolic models for numerous HGM
microorganisms have been published (Thiele et al., 2005, 2011,
2012; Orth et al., 2011; Branco Dos Santos et al., 2013; Heinken
et al., 2013, 2014; Bauer et al., 2015), but still require better
coverage of the respiratory chain and quinone biosynthesis
pathways. At the same time, computational models for human
metabolism (Duarte et al., 2007; Sahoo et al., 2012, 2015; Heinken
et al., 2013; Thiele et al., 2013a,b) are available, thereby, enabling
the in silico study of HGM and their interactions with each other
(Freilich et al., 2011; Zomorrodi and Maranas, 2012; Khandelwal
et al., 2013; Heinken and Thiele, 2015a) as well as with the human
host (Thiele et al., 2013a; Bauer et al., 2015; Heinken and Thiele,
2015b,c). Particularly, such a modeling approach could help us to
estimate the microbial contribution to the MK requirements in
humans.
Quinone biosynthesis has been studied inmany taxonomically
diverse microbial species (Collins and Jones, 1981; Meganathan,
2001b; Shearer and Newman, 2008; Nowicka and Kruk, 2010;
Cluis et al., 2012), but no systematic analysis of quinone
biosynthesis has yet been done for microbes found in a
particular ecosystem. Considering that many microbes remain
unculturable, as their culturing conditions remain unidentified,
it is crucial to search their genomes for potential exchanges
of metabolites with other community members. Particularly,
quinones may play an important role in the co-metabolism
of microbial communities, as they are main electron transfer
molecules in microbial respiratory chains. Quinones influence
the energy production and further, through cellular redox status
and central metabolism, they affect the utilization of carbon and
nitrogen sources and biosynthesis of indispensable compounds,
such as amino and fatty acids. Thus, the ability of a microbe to
de novo synthetize, salvage, or utilize quinones determines vital
cellular properties, such as growth and replication. The presented
results of the distribution of quinone biosynthetic pathways could
be further expanded to include strains with high relevance in the
Frontiers in Microbiology | www.frontiersin.org 10 February 2016 | Volume 7 | Article 128
Ravcheev and Thiele Quinone Biosynthesis in the Human Gut Microbiota
biotechnological industry, in ecology, and in human health. Such
large-scale comparative genomics effort could provide further
insight into evolutionary mechanisms, including co-evolution of
microbiomes with the host.
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